NCT02672163View on ClinicalTrials.gov

Autologous Atrial Appendage Derived Cells in the Treatment of Heart Failure

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Heart Failure
Interventions
PROCEDURE

CABG surgery

Elective CABG surgery

PROCEDURE

AADC therapy

Atrial appendage derived cells are placed on the site of a infarct scar with matrix sheet

Trial Locations (1)

00029

Annu Nummi, Helsinki

All Listed Sponsors
lead

Helsinki University Central Hospital

OTHER

NCT02672163 - Autologous Atrial Appendage Derived Cells in the Treatment of Heart Failure | Biotech Hunter | Biotech Hunter